Sally Temple, Ph.D., named to National Academy of Medicine

Jeffrey Stern M.D., Ph.D., and Sally Temple, Ph.D.

Sally Temple, Ph.D., an adjunct faculty member at Kellogg, is among the 2022 inductees into the National Academy of Medicine. Co-Founder and Scientific Director of the Neural Stem Cell Institute, Dr. Temple’s pioneering work in stem cell biology is driving new therapies for neurodegenerative disorders of the brain and retina. As detailed in this year’s report, Kellogg is the first site of a Phase 1/2a clinical trial of the transplantation of allogeneic retinal pigment epithelial stem cells into the retina as a treatment for dry AMD, an approach based on Dr. Temple’s pre-clinical modeling work with her husband, retina specialist Jeffrey Stern M.D., Ph.D.